PubMed · 8211341
Platelet dysfunction associated with clozapine therapy.
Abstract
Clozapine, an atypical antipsychotic agent used in cases of treatment-resistant schizophrenia, is known for its relative absence of extrapyramidal side effects and its potential hazardous effect on white blood cell function. We have described a case of clozapine-associated epistaxis and reduction of the platelet count. Discontinuance of clozapine therapy resulted in cessation of epistaxis followed by normalization of the platelet count. We suggest routine monitoring of platelet count and function in patients treated with clozapine.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
R Durst, A Dorevitch, Y Fraenkel. 1993. Platelet dysfunction associated with clozapine therapy.. https://doi.org/10.1097/00007611-199310000-00021. https://pubmed.health/record/pubmed%3A8211341/platelet-dysfunction-associated-with-clozapine-therapy
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.